Good Clinical Practice Inspections Take On Narrower Focus During Pandemic, US FDA Says

 
• By Sue Sutter
  
Tunnel vision
FDA inspectors have narrowed the focus of good clinical practice assessments due to technological and logistical challenges resulting from the pandemic. • Source: Alamy

More from Clinical Trials

More from R&D